Market Cap (In KRW)
194.95 Billion
Revenue (In KRW)
97.1 Billion
Net Income (In KRW)
23.21 Billion
Avg. Volume
62.19 Thousand
- Currency
- KRW
- Country
- Consumer Defensive
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 11000.0-34300.0
- PE
- -
- EPS
- -
- Beta Value
- 0.929484
- ISIN
- KR7092730001
- CUSIP
- -
- CIK
- -
- Shares
- 15254534.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Byeong-Deog Park
- Employee Count
- -
- Website
- http://www.neopharm.co.kr
- Ipo Date
- 2007-01-30
- Details
- NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. Its products include emulsified and functional skin care products for sensitive and dry skin, treatment of atopic dermatitis and psoriasis, and therapy for steroid side effects. The company was founded on July 1, 2000 and is headquartered in Daejeon, South Korea.
More Stocks
-
SAME
-
002664
-
ARPC
-
032560
-
LFPILifePoint, Inc.
LFPI
-
029530sindoh Co.,Ltd.
029530
-
BPCPBioPharma Credit PLC
BPCP
-
6099Elan Corporation
6099